These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1357312)
1. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors. Olbricht CJ; Schaumann D; Fischer D Lancet; 1992 Oct; 340(8824):908-9. PubMed ID: 1357312 [No Abstract] [Full Text] [Related]
2. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption. Kroon AA; Mol MJ; Stalenhoef AF Lancet; 1992 Dec; 340(8833):1476. PubMed ID: 1360599 [No Abstract] [Full Text] [Related]
3. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor. Koga N; Nagano T; Sato T; Kagasawa K ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns. Koga N Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391 [TBL] [Abstract][Full Text] [Related]
12. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia. Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773 [No Abstract] [Full Text] [Related]
13. Establishing low-density lipoprotein apheresis tolerability in patients with prior anaphylactoid reactions to lipoprotein apheresis using magnesium sulfate. Alexander E; Moriarty PM; Wilk B; Eliaz I J Clin Apher; 2021 Jun; 36(3):437-442. PubMed ID: 33599029 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy. Gordon BR; Saal SD J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816 [TBL] [Abstract][Full Text] [Related]
15. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns. Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547 [TBL] [Abstract][Full Text] [Related]
16. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques. Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309 [TBL] [Abstract][Full Text] [Related]
17. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation. Grützmacher P; Landgraf H; Esser R; Okon J; Vlachojannis J; Ehrly AM; Schoeppe W ASAIO Trans; 1990; 36(3):M327-30. PubMed ID: 2252691 [TBL] [Abstract][Full Text] [Related]
18. Unmasking hypotension by beta lactam during dextran sulfate low-density lipoprotein apheresis. Takenaka T; Sakamoto M; Suzuki H Am J Kidney Dis; 2004 Dec; 44(6):e107-8. PubMed ID: 15558512 [TBL] [Abstract][Full Text] [Related]
19. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis. Bosch T Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411 [TBL] [Abstract][Full Text] [Related]
20. Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies. Schechner V; Ben-Ami R; Hershcovici T; Yedgar S; Beigel Y; Shapira I; Berliner S; Barsthein G Ther Apher Dial; 2005 Oct; 9(5):379-84. PubMed ID: 16202011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]